Research Article
SARS-CoV-2-Specific T Cell Immunity in HIV-Associated Kaposi Sarcoma Patients in Zambia
Figure 1
SARS-CoV-2-specific T cell responses between baseline and follow-up. (a) T cell responses against spike S1 subunit at baseline and follow-up. (b) T cell responses against NMO at baseline and follow-up.
(a) |
(b) |